April 18 (Reuters) - CSL Ltd (CSL) :
- CSL BEHRING RECEIVES FDA APPROVAL FOR HIZENTRA® (IMMUNE GLOBULIN SUBCUTANEOUS 20% LIQUID) 50ML PREFILLED SYRINGE
- CSL LTD - 50ML PREFILLED SYRINGE WILL BE AVAILABLE IN EARLY 2024
News: CSL Csl Behring Receives FDA Approval For Hizentra® (Immune Globulin Subcutaneous <Origin...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$263.85 |
Change
8.540(3.34%) |
Mkt cap ! $127.6B | |||
| Open | High | Low | Value | Volume |
| $258.12 | $264.16 | $257.91 | $158.2M | 604.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 58 | $263.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $263.86 | 48 | 4 |
View Market Depth
| Last trade - 13.54pm 22/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |